AURORA SPINE CORP - ASAPF STOCK NEWS

Welcome to our dedicated page for AURORA SPINE news (Ticker: ASAPF), a resource for investors and traders seeking the latest updates and insights on AURORA SPINE stock.

Aurora Spine Corp (ASAPF) is a pioneering company in the spinal implant market, focusing on innovative, minimally invasive, and regenerative spinal implant technologies. Recently, the company introduced Ghost Tube™, a groundbreaking product designed for superior anchoring during surgical procedures. With a translucent thermoplastic body and non-slipping titanium anchors, Ghost Tube™ ensures stable surgical access without obstructing x-ray visibility. President & CEO, Trent Northcutt, expressed enthusiasm for the newly received patent, emphasizing its support for the SiLO TFX SI Fusion System and the development of future radiolucent tools. Chief Technology Officer, Laszlo Garamszegi, highlighted the company's commitment to disruptive and innovative technologies, aiming to enhance patient care and outcomes. Aurora Spine continues to expand its product and intellectual property portfolio, striving to deliver efficient solutions and improve treatment options.

01/29/2024 07:30 AM

News

The United States Patent Office Grants New Patent for Aurora Spine’s Translucent GhostTube™ Surgical Operating Tube

Rhea-AI Summary

Aurora Spine Corporation has announced the issuance of its United States Patent No: 11,832,853 entitled 'Hybrid Radiolucent Surgical Operating Tube'. The patent is for the Ghost Tube™, a translucent thermoplastic body with non-slipping titanium anchors designed to support surgical preparation tools without blocking x-ray visualization during surgery. This patent supports the recently launched SiLO TFX SI Fusion System and will allow the company to create new radiolucent tools for future product lines. Aurora Spine aims to continue being disruptive and innovative in delivering products and improving treatment options for better patient care and outcomes.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.92%

Tags

01/18/2024 07:21 AM

News

AURORA SPINE ANNOUNCES ATTENDANCE AT NORTH AMERICAN NEUROMODULATION SOCIETY (NANS) ANNUAL MEETING

Rhea-AI Summary

Aurora Spine Corporation, a medical device manufacturer, will be participating in the NANS Annual Meeting to showcase its Sacroiliac Joint fusion products. The company will also present data from a recent clinical evaluation of its ZIP Interspinous Fixation device.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

01/08/2024 07:30 AM

News

Aurora Spine Announces Attendance at J.P. Morgan Healthcare Conference

Rhea-AI Summary

Aurora Spine Corporation (ASG) to attend J.P. Morgan Healthcare Conference, President and CEO to present company's story to financial institutions and individuals

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

11/13/2023 05:14 PM

News

Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Third Quarter Fiscal Year 2023 Financial Results

Rhea-AI Summary

Aurora Spine Corporation (ASG) Announces Conference Call to Discuss Q3 Fiscal 2023 Financial Results

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

4.13%

Tags

10/23/2023 07:15 AM

News

AURORA SPINE ANNOUNCES CLOSING OF PRIVATE PLACEMENT FINANCING

Rhea-AI Summary

Aurora Spine completes private placement offering of units for gross proceeds of approximately CDN$1.9 million. The Company issued 6,445,939 Units at a price of CDN$0.30 per Unit. The proceeds will be used to fund increased working capital resulting from expected sales growth of new products.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-0.66%

Tags

09/13/2023 07:15 AM

News

Aurora Spine Announces Full Release of its SiLO TFX™ MIS Sacroiliac Joint Fixation System

Rhea-AI Summary

Aurora Spine announces full commercial release of SiLO TFX MIS Sacroiliac Joint Fixation Device system

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

5.57%

Tags

08/28/2023 07:15 AM

News

Aurora Spine Corporation Schedules Conference Call to Update Investors and Discuss Second Quarter Fiscal Year 2023 Financial Results

Rhea-AI Summary

Aurora Spine Corp. to hold conference call for Q2 fiscal 2023 financial results on August 29, 2023.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

9.2%

Tags

06/28/2023 07:30 AM

News

Aurora Spine Announces Initial Patient Enrolled for DEXA-CTM Multicenter Study

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-1.35%

Tags

05/23/2023 07:15 AM

News

Aurora Spine Corporation Schedules Release of First Quarter Fiscal Year 2023 Financial Results and Conference Call

Rhea-AI Summary

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-2.34%

Tags

04/26/2023 01:18 PM

News

Aurora Spine Corporation Schedules Release of Fourth Quarter and Fiscal Year 2022 Financial Results and Conference Call

Rhea-AI Summary

Aurora Spine Corporation (OTCQB: ASAPF) will release its financial results for Q4 and FY 2022 on May 1, 2023. The conference call is scheduled for 12:00 p.m. ET to discuss these results. Interested participants can join the call via a toll-free number or through a live webcast. The replay of the conference will be accessible for a week post-call. The company specializes in innovative spinal implant technologies aimed at enhancing surgical outcomes.

Aurora emphasizes transparency, indicating that forward-looking statements may pose risks and uncertainties. Readers are advised not to overly rely on projections made in the release.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

Tags

FAQ

What is the current stock price of AURORA SPINE (ASAPF)?

The current stock price of AURORA SPINE (ASAPF) is $0.31956 as of January 22, 2025.

What is the market cap of AURORA SPINE (ASAPF)?

The market cap of AURORA SPINE (ASAPF) is approximately 22.3M.

What is Aurora Spine Corp known for?

Aurora Spine Corp is recognized for its innovative and minimally invasive spinal implant technologies, aimed at improving patient outcomes.

What is Ghost Tube™ and its significance?

Ghost Tube™ is a pioneering product by Aurora Spine Corp, designed for superior anchoring during surgical procedures. Its translucent thermoplastic body and non-slipping titanium anchors ensure stable surgical access without obstructing x-ray visibility.

Who are the key figures at Aurora Spine Corp?

Trent Northcutt serves as the President & CEO of Aurora Spine Corp, leading the company's strategic direction and growth. Chad Clouse is the Chief Financial Officer, overseeing financial operations.

What recent achievements has Aurora Spine Corp celebrated?

Aurora Spine Corp recently received a patent for Ghost Tube™, reinforcing its product portfolio and intellectual property. The company continues to focus on disruptive and innovative technologies.

How does Aurora Spine Corp contribute to the healthcare industry?

Aurora Spine Corp contributes to the healthcare industry by providing cutting-edge solutions for spinal implant procedures, enhancing patient care and outcomes.

What is the vision of Aurora Spine Corp for the future?

Aurora Spine Corp aims to continue being a leader in the spinal implant market, delivering efficient products and creating new treatment options to meet the evolving needs of patients.

Where can I find more information about Aurora Spine Corp?

For additional information about Aurora Spine Corp, including its products, technologies, and achievements, visit their official website at www.aurora-spine.com.

How can investors get in touch with Aurora Spine Corp?

Investors can contact Aurora Spine Corp through the provided contact details on their website or by reaching out to Trent Northcutt, President & CEO, or Chad Clouse, Chief Financial Officer.

What sets Aurora Spine Corp apart from its competitors?

Aurora Spine Corp stands out from its competitors due to its focus on innovative, minimally invasive, and regenerative spinal implant technologies, aimed at revolutionizing the industry.

What are the core values of Aurora Spine Corp?

Aurora Spine Corp prioritizes innovation, patient care, and technological advancement, driving its mission to provide cutting-edge solutions for the spinal implant market.